ER
TEVA icon

Enlightenment Research’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Enlightenment Research’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-19,000
Closed -$143K – 153
2022
Q2 		$143K Buy
+19,000
New +$166K 0.31% 87
2019
Q1 		– Sell
-12,100
Closed -$187K – 617
2018
Q4 		$187K Buy
+12,100
New +$248K 0.23% 91

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Enlightenment Research's TEVA Position: Q3 2022 in Review

Enlightenment Research sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q3 2022, closing a stake of 19,000 shares — an estimated $143K sold.

Enlightenment Research first reported a position in TEVA in Q4 2018 and held it in 2 quarters. The position peaked at $187K in Q4 2018. 430 funds tracked by Wall St. Rank hold TEVA as of Q3 2022.

  • Enlightenment Research reported no remaining Teva Pharmaceutical Industries Limited position as of Q3 2022 after selling out during the quarter.
  • Enlightenment Research sold 19,000 Teva Pharmaceutical Industries Limited shares in Q3 2022, an estimated $143K.
  • Enlightenment Research first reported a position in Teva Pharmaceutical Industries Limited in Q4 2018 and held it in 2 quarters.
  • Enlightenment Research's Teva Pharmaceutical Industries Limited position peaked at $187K in Q4 2018.
  • 430 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q3 2022.

Based on Enlightenment Research's 13F filing for Q3 2022, filed 15 Nov 2022.